Hélène LaRue

1.8k total citations
49 papers, 1.5k citations indexed

About

Hélène LaRue is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Hélène LaRue has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 25 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Hélène LaRue's work include Bladder and Urothelial Cancer Treatments (24 papers), Immunotherapy and Immune Responses (11 papers) and Glycosylation and Glycoproteins Research (9 papers). Hélène LaRue is often cited by papers focused on Bladder and Urothelial Cancer Treatments (24 papers), Immunotherapy and Immune Responses (11 papers) and Glycosylation and Glycoproteins Research (9 papers). Hélène LaRue collaborates with scholars based in Canada, United States and Sweden. Hélène LaRue's co-authors include Yves Fradet, Alain Bergeron, Louis Lacombe, Hélène Hovington, Lynne Moore, François Harel, Tahar Aboulkassim, Bernard Têtu, François Meyer and Luc Bélanger and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Hélène LaRue

49 papers receiving 1.4k citations

Peers

Countries citing papers authored by Hélène LaRue

Since Specialization

Citations

This map shows the geographic impact of Hélène LaRue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène LaRue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène LaRue more than expected).

Fields of papers citing papers by Hélène LaRue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène LaRue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène LaRue. The network helps show where Hélène LaRue may publish in the future.

Co-authorship network of co-authors of Hélène LaRue

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène LaRue. A scholar is included among the top collaborators of Hélène LaRue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène LaRue. Hélène LaRue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes	Frontiers in Immunology	Hélène LaRue, David Simonyan et al.	5
2	High infiltration of CD209+ dendritic cells and CD163+ macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes	Frontiers in Immunology	Hélène LaRue, David Simonyan et al.	5
3	Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study	Cancers	Hélène LaRue, Hélène Hovington et al.	1
4	Poly(I:C) potentiates Bacillus Calmette–Guérin immunotherapy for bladder cancer	Cancer Immunology Immunotherapy	Alain Bergeron, Hélène LaRue et al.	21
5	Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non–Muscle-Invasive Bladder Cancer: A Gene–Smoking Interaction	Cancer Prevention Research	Louis Lacombe, Vincent Fradet et al.	10
6	High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer	Human Pathology	Hélène LaRue, Hélène Hovington et al.	31
7	High frequency of MAGE‐A4 and MAGE‐A9 expression in high‐risk bladder cancer	International Journal of Cancer	Alain Bergeron, Valérie Picard et al.	75
8	Maintenance bacillus Calmette‐Guérin in high‐risk nonmuscle‐invasive bladder cancer	Cancer	Hélène LaRue, François Harel et al.	28
9	Tissue factor expression correlates with disease‐specific survival in patients with node‐negative muscle‐invasive bladder cancer	International Journal of Cancer	Hélène Hovington, Hélène LaRue et al.	43
10	Alteration of the PATCHED locus in superficial bladder cancer	Oncogene	Tahar Aboulkassim, Hélène LaRue et al.	44
11	Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy	The Prostate	J. Rigaud, Rabi Tiguert et al.	25
12	P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers	Carcinogenesis	Hélène LaRue	34
13	Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest	Oncogene	Hélène LaRue, Tahar Aboulkassim et al.	57
14	Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes	International Journal of Cancer	Christian Pfister, Hélène LaRue et al.	2
15	Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31	Oncogene	Tahar Aboulkassim, Hélène LaRue et al.	84
16	Deletions of the INK4A Gene in Superficial Bladder Tumors	American Journal Of Pathology	Irene Orlow, Hélène LaRue et al.	110
17	Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancer	International Journal of Cancer	Hélène LaRue, Alain Bergeron et al.	8
18	MAUB Is a New Mucin Antigen Associated with Bladder Cancer	Journal of Biological Chemistry	Alain Bergeron, Serge Champetier et al.	17
19	Strategies of chemoprevention based on antigenic and molecular of early and premalignant lesions of the bladder	Journal of Cellular Biochemistry	Yves Fradet, Hélène LaRue et al.	7
20	Monoclonal antibody against a tumor‐associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomas	International Journal of Cancer	Yves Fradet, Hélène LaRue et al.	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact